title: [Management of biliary tract carcinomas].
abstract: Biliary tract carcinomas are rare tumours, counting for less than 5% of cancer. Biliary tract carcinomas comprise gallbladder carcinoma and cholangiocarcinoma, which arise from the intrahepatic or extrahepatic bile ducts. These tumours have a poor prognosis, with a median survival of 6 months for advanced disease. Surgical resection is the only potentially curative therapy. Adjuvant treatement by chemotherapy, radiotherapy or radio-chemotherapy might be an option after surgery, however no standard therapy is define. For advanced disease, despite progress of palliative chemotherapy, there is no standard therapy.
authors.affiliation: Service d'oncologie médicale, université Paris-12, AP-HP, hôpital Henri-Mondor, 94000 Créteil. catherine.delbaldo@hmn.aphp.fr
authors.forename: Catherine
authors.initials: C
authors.lastname: Delbaldo
authors.forename: Alexis
authors.initials: A
authors.lastname: Laurent
authors.forename: Julien
authors.initials: J
authors.lastname: Grenier
authors.forename: Daniel
authors.initials: D
authors.lastname: Cherqui
authors.forename: Alain
authors.initials: A
authors.lastname: Luciani
authors.forename: Pascal
authors.initials: P
authors.lastname: Piedbois
mesh_terms: D001661:Biliary Tract Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006801:Humans